Dyadic International (NASDAQ:DYAI) Stock Passes Above Fifty Day Moving Average – Time to Sell?

Dyadic International, Inc. (NASDAQ:DYAI)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.56 and traded as high as $1.99. Dyadic International shares last traded at $1.73, with a volume of 171,662 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and set a $6.00 price target on shares of Dyadic International in a research report on Thursday, November 14th.

Dyadic International Stock Down 4.3 %

The firm has a 50-day moving average price of $1.57 and a 200 day moving average price of $1.39. The company has a debt-to-equity ratio of 1.54, a current ratio of 5.15 and a quick ratio of 5.15. The company has a market cap of $48.82 million, a price-to-earnings ratio of -7.17 and a beta of 0.89.

Dyadic International (NASDAQ:DYAI) last posted its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.06. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. The company had revenue of $1.96 million for the quarter, compared to the consensus estimate of $1.05 million. During the same quarter in the prior year, the business earned ($0.06) earnings per share. Sell-side analysts predict that Dyadic International, Inc. will post -0.18 EPS for the current year.

Institutional Investors Weigh In On Dyadic International

A hedge fund recently raised its stake in Dyadic International stock. Chapin Davis Inc. boosted its holdings in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 868,301 shares of the biotechnology company’s stock after purchasing an additional 21,000 shares during the period. Chapin Davis Inc. owned about 2.97% of Dyadic International worth $903,000 at the end of the most recent quarter. Institutional investors own 27.95% of the company’s stock.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.